Antonio C. Wolff

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC).

A. Wolff, N. Davidson, M. Rudek, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

A. Wolff, J. Verweij, S. Baker, 2004, European journal of cancer.

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer.

A. Wolff, J. Sparano, L. Rajdev, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.